Hulshof, M M <br/><br/>
Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Dec 2000 
 - 1017-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0190-9622 
<br/><br/><label>Standard No.: </label>10.1067/mjd.2000.108369  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Calcitriol--administration & dosage<br/>Calcium Channel Agonists--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Reference Values<br/>Scleroderma, Localized--diagnosis<br/>Scleroderma, Systemic--diagnosis<br/>Treatment Outcome